The concept of generating iTSCs through the overexpression of ALDOA presents an intriguing paradox, considering that ALDOA, a glycolytic enzyme, exhibits heightened expression in diverse tumor types, often being linked to tumorigenesis and the advancement of the disease [41]. The gene discussed is ALDOA; the disease is neoplasm.